Sample Patient Profile
Sample Patient Profile
Sample Patient Profile
Laboratory Procedures
Laboratory Blood Test Results
Na 147 meq/L Plt 160 x10 103/mm3 Bilirubin, total 0.3 mg/dL
K 4.1 meq/L WBC 9.1 x10 103/mm3 PT 14.2 sec
Cl 114 meq/L PMNs 62% Alb 4.0 g/dL
HCO3 25 meq/L Lymphs 27% Protein, total 6.8 g/dL
BUN 29 mg/dL Eos 3% Alk phos 78 IU/L
Cr 1.1 mg/dL Basos 1% Ca 8.8 mg/dL
Glu, fasting 98 mg/dL Monos 7% PO4 3.5 mg/dL
Hb 19.3 g/dL AST 14 IU/L Mg 2.5 mg/dL
Hct 55% ALT 31 IU/L AAT 137 mg/dL
Chest X-Rays
• Hyperinflation with flattened diaphragm
• Large anteroposterior diameter
• Diffuse scarring and bullae in all lung fields but especially prominent in lower lobes bilaterally
• No effusions or infiltrates
• Large pulmonary vasculature
Surgical Management
The patient hasn’t undergone any surgical management.
Pharmacological Management
• HCTZ 25 mg po Q AM
• Amlodipine 5 mg po QD
• Theophylline 200 mg po BID
• Albuterol 180 µg MDI 2 inhalations QID PRN
• Ipratropium 36 µg MDI 2 inhalations QID
• The patient has been compliant with his medications. However, he admits that he does not
like to use ipratropium because it causes “dry mouth” and makes him feel “edgy.”.
Course of Management
The goal of COPD management is to improve a patient’s functional status and quality of life by
preserving optimal lung function; improving symptoms and preventing recurrence of exacerbation.
Smoking cessation greatly decreases episodes of exacerbation. Oxygen therapy also helps to maintain
the patients lung functions. His medications helps control and manage the inflammation and infection
that comes with COPD. Sputum viscosity and Secretion clearance should also be properly managed to
improve symptoms.